sulfinpyrazone has been researched along with Arterial Obstructive Diseases in 14 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients treated with sulfinpyrazone, an apparent reduction in the incidence of sudden death and presumed ventricular fibrillation has been reported." | 7.66 | Effect of sulfinpyrazone on ventricular fibrillation during acute myocardial ischemia. ( Escobinas, AJ; Jorgensen, OB; Moschos, CB; Regan, TJ, 1981) |
| "In patients treated with sulfinpyrazone, an apparent reduction in the incidence of sudden death and presumed ventricular fibrillation has been reported." | 3.66 | Effect of sulfinpyrazone on ventricular fibrillation during acute myocardial ischemia. ( Escobinas, AJ; Jorgensen, OB; Moschos, CB; Regan, TJ, 1981) |
| " It is concluded that when initiating and withdrawing treatment with SP in a patient receiving AC, the prothrombin time should be checked daily for a few days to adapt (reduce) the dosage of AC to the change in prothrombin time induced by SP." | 2.65 | [The effect of sulfinpyrazone on the coagulation-inhibiting action of acenocoumarol]. ( Fontanilles, F; Holt, NF; Michot, F, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Comberg, HU | 1 |
| Janssen, EJ | 1 |
| Diehm, C | 1 |
| Zimmermann, R | 1 |
| Harenberg, J | 1 |
| Walter, E | 1 |
| Oster, P | 1 |
| Allenberg, J | 1 |
| Horsch, AK | 1 |
| Mörl, H | 1 |
| Cain, TD | 1 |
| Wood, JS | 1 |
| Beard, OW | 1 |
| Michot, F | 1 |
| Holt, NF | 1 |
| Fontanilles, F | 1 |
| Cristol, R | 1 |
| Moschos, CB | 1 |
| Escobinas, AJ | 1 |
| Jorgensen, OB | 1 |
| Regan, TJ | 1 |
| Verstraete, M | 1 |
| Vigdahl, RL | 1 |
| Ferber, RH | 1 |
| Parrish, SL | 1 |
| Ostendorf, P | 1 |
| Regli, F | 1 |
| Michaud, PA | 1 |
| Loew, D | 1 |
| Genton, E | 1 |
| Gent, M | 1 |
| Hirsh, J | 1 |
| Harker, LA | 2 |
| Bollinger, A | 1 |
| Di Perri, T | 1 |
4 reviews available for sulfinpyrazone and Arterial Obstructive Diseases
| Article | Year |
|---|---|
Medical Grand Rounds: extracranial carotid artery disease.
Topics: Adolescent; Adult; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Auscultation; Carotid Art | 1980 |
[Platelet antiaggregants and arteriopathies].
Topics: Arterial Occlusive Diseases; Aspirin; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyr | 1981 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Tria | 1975 |
Antiplatelet drugs in the management of patients with thrombotic disorders.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Blood Platelets | 1986 |
5 trials available for sulfinpyrazone and Arterial Obstructive Diseases
| Article | Year |
|---|---|
[Sulfinpyrazone (Anturan) versus placebo following surgical reconstruction of the femoral artery in arterial occlusive diseases].
Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis; Clinical Trials as Topic; Double-Blind M | 1983 |
Medical Grand Rounds: extracranial carotid artery disease.
Topics: Adolescent; Adult; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Auscultation; Carotid Art | 1980 |
[The effect of sulfinpyrazone on the coagulation-inhibiting action of acenocoumarol].
Topics: Acenocoumarol; Adult; Aged; Arterial Occlusive Diseases; Blood Coagulation; Clinical Trials as Topic | 1981 |
Internation Committee on Thrombosis and Haemostasis Basil, 8.-11. September 1974 Subcommittee on Clinical Investigations: Registry of prospective clinical trials.
Topics: Ancrod; Animals; Arterial Occlusive Diseases; Aspirin; Batroxobin; Clinical Trials as Topic; Fibrino | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Tria | 1975 |
7 other studies available for sulfinpyrazone and Arterial Obstructive Diseases
| Article | Year |
|---|---|
Effect of sulfinpyrazone on ventricular fibrillation during acute myocardial ischemia.
Topics: Acute Disease; Animals; Arterial Occlusive Diseases; Blood Pressure; Coronary Disease; Dogs; Electro | 1981 |
Evaluation of antiinflammatory and antithrombotic drugs in pulmonary and arterial thrombosis.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Anti-Inflammatory Agents; Arterial Occlusive Di | 1979 |
[Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions].
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cerebral Infarction; Cerebrovascular Disorders | 1979 |
[Treatment of transient ischemic attacks (author's transl)].
Topics: Angiography; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Endarterectomy; Humans; Ischemic | 1978 |
[Results of clinical studies on the effect of aggregation inhibitors in arterial diseases].
Topics: Arterial Occlusive Diseases; Aspirin; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1979 |
[Secondary prevention of peripheral arterial occlusive diseases].
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Coumarins; Dipyridamole; Humans; Sulfinp | 1987 |
[Prevention and medical treatment of polyregional vascular lesions].
Topics: Adult; Anticoagulants; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Diet; Dipyridamole; D | 1985 |